Wells Fargo & Company Trims CVS Health (NYSE:CVS) Target Price to $76.00
CVS Health (NYSE:CVS – Free Report) had its target price reduced by Wells Fargo & Company from $83.00 to $76.00 in a research report released on Monday, Benzinga reports. They currently have an equal weight rating on the pharmacy operator’s stock. A number of other equities research analysts have also recently weighed in on the […]
More Stories
Litigation Capital Management’s (LIT) “Buy” Rating Reaffirmed at Canaccord Genuity Group
Litigation Capital Management (LON:LIT – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at Canaccord Genuity...
Occupied Palestinian Territory: Security Council hears of ongoing violence, ‘relentless’ Israeli settlement expansion
The United Nations continues to voice major concern over hostilities and Israeli settlement expansion in the Occupied Palestinian Territory (OPT),...
IntegraFin (LON:IHP) Trading Down 12.2% – What’s Next?
IntegraFin Holdings plc (LON:IHP – Get Free Report) dropped 12.2% during mid-day trading on Wednesday . The company traded as...
Horizon Kinetics Inflation Beneficiaries ETF (NYSEARCA:INFL) Sees Strong Trading Volume – Here’s What Happened
Horizon Kinetics Inflation Beneficiaries ETF (NYSEARCA:INFL – Get Free Report) saw an uptick in trading volume on Wednesday . 363,483...
NovoCure (NASDAQ:NVCR) Hits New 1-Year High – Here’s What Happened
NovoCure Limited (NASDAQ:NVCR – Get Free Report) shares hit a new 52-week high during mid-day trading on Wednesday . The...
ARM (NASDAQ:ARM) Stock Price Up 1.5% – Still a Buy?
Arm Holdings plc (NASDAQ:ARM – Get Free Report) rose 1.5% during trading on Wednesday . The company traded as high...